$1.49
-0.06-3.87%
Last update: Nov 12, 7:25 PM
Can Fite Biopharma Ltd
CANFAMEX
Can Fite Biopharma fell 80.0% from $7.74 to $1.55, behind the S&P 500's +10.8%. Its worst day was Sep 2 (−28.3%), and its low came Nov 11 at $1.55.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Can Fite Biopharma shares fell 25.0%, while the S&P 500 rose 0.4%.
−25.0% · S&P 500 +0.4%
Story events cover the past 12 months · Times ET
Can Fite Biopharma shares rose 18.3%, while the S&P 500 fell 0.3%.
+18.3% · S&P 500 −0.3%
Can Fite Biopharma shares fell 23.6%, while the S&P 500 fell 0.6%.
−23.6% · S&P 500 −0.6%
EPS of $-5.97 beat the $-10.40 estimate on $405,000.00 revenue (est. $202,000.00).
+1.9% · S&P 500 −1.8%
Can Fite Biopharma shares rose 55.9%, while the S&P 500 fell 0.1%.
+55.9%, the year's best day, on 57M shares, the year's heaviest volume · S&P 500 −0.1%
EPS of $-1.24 beat the $-1.43 estimate on $202,000.00 revenue.
+2.7% · S&P 500 −0.5%
Where it ended: a close of $1.55 on Nov 11, 2026.
Nothing in the past 12 months.
All CANF dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CANF and SPY from Benzinga historical bars. Not investment advice.
